文献速递细菌感染、耐药与抗菌药物

耐药血流感染中抗菌治疗与临床结局关联的术语、定义与方法学系统综述

Nomenclature, definitions, and methodological approaches to estimate the association between antimicrobial treatment and clinical outcomes of drug-resistant bloodstream infections.
PubMed 文献 · Clin Microbiol Infect · 2025-08-06

该系统综述纳入187项研究(多为队列研究),分析耐药ESKAPE病原血流感染中初始抗菌治疗错配的术语与定义,并评估其与死亡率和住院时长的关联分析方法。结果显示术语以「(不)适当」为主(74.3%),定义主要基于体外药敏(98.4%),65.6%的研究报告错配与死亡率相关,但所有研究均存在高偏倚风险。

要点

  • 初始治疗错配术语以「(不)适当」最常见(74.3%),其次为「(不)充分」(18.2%)。
  • 定义主要基于处方抗生素的体外药敏(98.4%),可附加多达九项其他标准。
  • 186项研究中122项(65.6%)报告错配与死亡率相关,但无研究为低偏倚风险。

核心结论

  • 初始抗菌治疗错配的定义与效果分析方法差异大,偏倚风险高,阻碍数据合并并限制对因果效应的理解。
  • 需要指南以提高研究质量并统一未来研究方向。

研究设计与样本

  • 系统综述,检索PubMed和EMBASE(1990年1月至2024年8月)。
  • 纳入187项研究,其中183项为队列研究,对象为耐药ESKAPE病原血流感染患者。
  • 采用修订版Joanna Briggs Institute工具评估偏倚风险,定性综合数据。

主要发现

  • 从3627篇文献中纳入187项研究,主要术语为「(不)适当」(n=139,74.3%)和「(不)充分」(n=34,18.2%)。
  • 定义主要考虑处方抗生素的体外药敏(n=184,98.4%),可附加多达九项其他标准。
  • 186项研究评估错配对死亡率的影响,多用logistic或Cox回归,122项(65.6%)显示关联。
  • 9项研究中仅2项显示错配与住院时长相关,仅4项明确分析感染后住院时长。
  • 无研究低偏倚风险,主要因残余混杂和时间依赖偏倚。

临床怎么用

  • 临床解读初始治疗错配与结局的关联研究时,需注意定义异质性和高偏倚风险。
  • 未来研究应统一错配定义并控制时间依赖偏倚和混杂。

局限性

  • 纳入研究多为观察性设计,存在残余混杂和时间依赖偏倚,无低偏倚风险研究。
  • 初始治疗错配定义和效果分析方法差异大,阻碍数据合并。
  • 入院至感染时间和感染至治疗时间很少被考虑。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Antimicrobial resistance increases the risk of misaligned initial antibiotic treatment (IAT), as susceptibility data are typically delayed. The causal effect on patient outcomes, however, is unclear due to reliance on observational studies with methodological heterogeneity. OBJECTIVES: To describe the terminology and definitions for IAT misalignment and evaluate methods used to analyse its association with mortality and hospital length of stay (LOS) for patients with drug-resistant bloodstream infections (BSIs). METHODS: A systematic review. DATA SOURCES: PubMed and EMBASE: January 1990 to August 2024. STUDY ELIGIBILITY CRITERIA: We included studies on drug-resistant BSIs caused by ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter species, and other Enterobacterales). Eligible studies defined IAT misalignment and assessed its effect on mortality/LOS. PARTICIPANTS: Patients with drug-resistant BSIs. EXPOSURE: (mis)aligned IAT. ASSESSMENT OF RISK OF BIAS: Revised versions of the Joanna Briggs Institute tools. METHODS OF DATA SYNTHESIS: Qualitative synthesis. RESULTS: From 3627 screened publications, 187 studies were included, predominantly cohort studies (n = 183). The most common terminology for IAT misalignment was "(in)appropriate" (n = 139, 74.3%), followed by "(in)adequate" (n = 34, 18.2%). Definitions primarily considered in vitro susceptibility to prescribed antibiotic(s) (n = 184, 98.4%), with up to nine additional criteria. Impact of (in)appropriate IAT on mortality (n = 186) was mostly evaluated using logistic or Cox regression, including various confounder selection methods, showing an association in 122 of 186 studies (65.6%). Admission-to-infection time and infection-to-treatment time were rarely considered. Impact of (in)appropriate IAT on LOS was shown in two of nine studies. Only four studies explicitly analysed postinfection LOS. No study scored a low risk of bias, due to residual confounding and time-dependent bias. DISCUSSION: Wide variability of IAT definitions and impact analysis was observed, with a high risk of bias, hindering data aggregation and limiting understanding of the causal effect of inappropriate IAT on clinical outcomes. Guidelines are required to improve study quality and harmonize future research.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Hassoun-Kheir N, Redin MR, Labi AK, et al. Nomenclature, definitions, and methodological approaches to estimate the association between antimicrobial treatment and clinical outcomes of drug-resistant bloodstream infections. Clin Microbiol Infect. 2025. PMID: 40780552. doi:10.1016/j.cmi.2025.07.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。